Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

Blood (2012) 119 (5): 1123–1129.

https://doi.org/10.1182/blood-2011-08-376087

Published: 2012

Journal Articles

Dapsone as Second-Line Drug in Non-Splenectomized Patients with Chronic Idiopathic Thrombocytopenic Purpura (ITP): A Highly Cost Effective Option in a Developing Country.

Ajay Sharma, MD, Velu Nair, MD, Satya R. Das, MD, D.K. Mishra, MD, J. Kotwal, MD, Mohan B. Agarwal, MD

Blood (2006) 108 (11): 1073.

https://doi.org/10.1182/blood.V108.11.1073.1073

Published: 2006

Journal Articles

Thrombotic Complications in Young Adults at High Altitude Areas: An Indian Experience.

Velu Nair, MD, Ajay Sharma, MD, Satya R. Das, MD, D.K. Mishra, MD, J. Kotwal, MD, Mohan B. Agarwal, MD

Blood (2006) 108 (11): 4108.

https://doi.org/10.1182/blood.V108.11.4108.4108

Published: 2006

Journal Articles

Chimeric Anti CD-20 Monoclonal Antibody-Rituximab in Refractory Childhood Idiopathic Thrombocytopenic Purpura: An Indian Experience.

Ajay Sharma, MD, Velu Nair, MD, Deepak K. Mishra, MD, Jyoti Kotwal, MD, Gurvinder S. Chopra, MD, PhD, N. K. Bhandari, MD, Mohan B. Agarwal, MD, Ramji Rai, MD

Blood (2005) 106 (11): 4010.

https://doi.org/10.1182/blood.V106.11.4010.4010

Published: 2005

Journal Articles

Stem Cell Transplantation: Impact of High Efficiency Particulate Air (HEPA) vs. Non-HEPA BMT Unit on Transplant Outcome: A Single Centre Experience from India.

Velu Nair, MD, Ajay Sharma, MD, Deepak K. Mishra, MD, Gurvinder S. Chopra, MD, PhD, J. Kotwal, MD, Mohan B. Agarwal, MD, N. K. Bhandari, MD, Ramji Rai, MD

Blood (2005) 106 (11): 5322.

https://doi.org/10.1182/blood.V106.11.5322.5322

Published: 2005

NARROW

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

Dapsone as Second-Line Drug in Non-Splenectomized Patients with Chronic Idiopathic Thrombocytopenic Purpura (ITP): A Highly Cost Effective Option in a Developing Country.

Thrombotic Complications in Young Adults at High Altitude Areas: An Indian Experience.

Chimeric Anti CD-20 Monoclonal Antibody-Rituximab in Refractory Childhood Idiopathic Thrombocytopenic Purpura: An Indian Experience.

Stem Cell Transplantation: Impact of High Efficiency Particulate Air (HEPA) vs. Non-HEPA BMT Unit on Transplant Outcome: A Single Centre Experience from India.

Email alerts

ASH Publications

American Society of Hematology

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

Dapsone as Second-Line Drug in Non-Splenectomized Patients with Chronic Idiopathic Thrombocytopenic Purpura (ITP): A Highly Cost Effective Option in a Developing Country.

Thrombotic Complications in Young Adults at High Altitude Areas: An Indian Experience.

Chimeric Anti CD-20 Monoclonal Antibody-Rituximab in Refractory Childhood Idiopathic Thrombocytopenic Purpura: An Indian Experience.

Stem Cell Transplantation: Impact of High Efficiency Particulate Air (HEPA) vs. Non-HEPA BMT Unit on Transplant Outcome: A Single Centre Experience from India.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only